Risk of non-Hodgkin lymphoma in celiac disease

JAMA

Volumn 287, Issue 11, 2002, Pages 1413-1419

  Catassi, Carlo ^a,b   Fabiani, Elisabetta ^b   Corrao, Giovanni ^d   Barbato, Maria ^e   De Renzo, Amalia ^f   Carella, Angelo M ^g   Gabrielli, Armando ^c   Leoni, Pietro ^c   Carroccio, Antonio ^h   Baldassarre, Mariella ⁱ   Bertolani, Paolo ^j   Caramaschi, Paola ^k   Sozzi, Michele ^l   Guariso, Graziella ^m   Volta, Umberto ^c   Corazza, Gino R ⁿ  

^a UNIVERSITY OF MARYLAND   (United States)

^b University Department of Pediatrics   (Italy)

^c University of Milano Bicocca ^*  (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ UNIVERSITY OF BARI   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k National Cancer Center   (United Kingdom)

^l CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^m UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

ⁿ University Department of Gastroenterology   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RISK; CELIAC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

EID: 0037139469     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.11.1413     Document Type: Article

References (47)

1. The clinical and biochemical syndrome in lymphoma and allied diseases involving the mesenteric lymph glands
2. Intestinal reticulosis as a complication of idiopathic steatorrhoea
3. Coeliac disease and malignancy
4. Coeliac-associated lymphoma: A single institution experience of 30 cases in the combination chemotherapy era
5. Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center
6. Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T-cell lymphomas
7. Malignant lymphoma in coeliac disease: Various manifestations with distinct symptomatology and prognosis?
8. Risk of lymphoma in patients with dermatitis herpetiformis
9. Malignancy in coeliac disease: Effect of a gluten-free diet
10. Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry
11. Primary lymphoma of the small intestine: A clinicopathological study of 119 cases
12. Celiac sprue
13. Increased incidence of malignancy in dermatitis herpetiformis
14. Mortality in celiac disease
15. Mortality in patients with coeliac disease and their relatives: A cohort study
16. Malignancy in coeliac disease
17. Coeliac disease in the year 2000: Exploring the iceberg
18. Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors
19. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease
20. Small bowel lymphoma in unrecognized coeliac disease: A cause for concern?
21. Cancer
22. Cancer surveillance series: Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995
23. The smaller size of the "coeliac iceberg" in adults
24. High prevalence of celiac disease in the Italian general population
25. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group)
26. The Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas, summary and description of a working formulation for clinical usage
27. Human umbilical cord as substrate for IgA entiendomysial antibodies allows large scale screening for celiac sprue
28. Revised criteria for diagnosis of coeliac disease
29. Attributable risk estimation in case-control studies
30. Variance estimators for attributable fraction estimates, consistent in both large strata and sparse data
31. Selection of controls in case-control studies
32. Pathological and immunophenotypic features of adult non-Hodgkin's lymphomas by age group
33. Relative frequencies and sites of presentation of lymphoid neoplasms in a community-hospital according to the revised European American classification
34. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma
35. Non-Hodgkin's lymphoma of the gastrointestinal tract: A population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis
36. The coeliac iceberg in Italy: A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects
37. High prevalence of undiagnosed coeliac disease in adults: A Swedish population-based study
38. New tool to predict celiac disease on its way to the clinics
39. Identification of tissue transglutaminase as the autoantigen of celiac disease
40. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice
41. Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders
42. Malignant lymphomas of the upper gastro intestinal tract: Results of a prospective study in 103 patients
43. Enteropathy associated T cell lymphoma presenting as an isolated CNS lymphoma three years after diagnosis of coeliac disease: T cell receptor polymerase chain reaction studies failed to show the original enteropathy to be a clonal disorder
44. Gluten, major histocompatibility complex, and the small intestine: A molecular and immunobiologic approach to the spectrum of gluten-sensitivity ("celiac sprue")
45. Multifocal small bowel lymphoma and latent celiac sprue
46. Coeliac disease: Associated disorders and survival